Mr. Speaker, Quebec's Minister of Industry and Commerce stated this morning before a parliamentary committee in Quebec City that the mere mention of a review of Bill C-91 caused the immediate postponement of a $50-million investment in Quebec's pharmaceutical industry.
Does the Minister of Finance, who is also responsible for regional development in Quebec, admit that a review of the drug-patent legislation would be disastrous for the brand-name drug industry, which is mainly concentrated in Montreal?